Stay updated with breaking news from Bioscience Stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Daré Bioscience (NASDAQ:DARE – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a research report issued on Monday, Benzinga reports. They presently have a $6.00 price objective on the biotechnology company’s stock. HC Wainwright also issued estimates for Daré Bioscience’s FY2025 earnings at $0.10 EPS, FY2026 earnings […]
Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) was the target of a large decline in short interest during the month of April. As of April 30th, there was short interest totalling 511,000 shares, a decline of 16.6% from the April 15th total of 612,400 shares. Based on an average trading volume of 203,300 shares, the […]
Shares of Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $1.08 and traded as low as $0.97. Daré Bioscience shares last traded at $0.98, with a volume of 74,549 shares traded. Analyst Ratings Changes A […]